
Rakovina Therapeutics Announces 2024 Financial Results and Provides Corporate Update
Rakovina Therapeutics Announces 2024 Financial Results and Provides Corporate Update Vancouver, BC, May 5, 2025--(T-Net)--Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through …